"TechCrunch…the U.S. Food and Drug Administration (FDA) has updated its Emergency Use Authorization guidelines to private labs that specifically bar the use of at-home sample collection. This means startups, including Everlywell, Carbon Health and Nurx, will have to immediately discontinue their testing programs in light of the clarified rules.
The FDA issued the updated guidance on March 21, and though some of the companies had already begun to ship their sample collection kits to people, and even begun to receive samples back to their diagnostic laboratory partners, even any samples in-hand will not be tested, and will instead be destroyed in order to comply with the FDA’s request..."
https://techcrunch.com/2020/03/23/updated-fda-covid-19-testing-guidelines-specifically-disallows-at-home-sample-colllection/
https://marginalrevolution.com/marginalrevolution/2020/03/fda-stops-at-home-tests.html
The FDA issued the updated guidance on March 21, and though some of the companies had already begun to ship their sample collection kits to people, and even begun to receive samples back to their diagnostic laboratory partners, even any samples in-hand will not be tested, and will instead be destroyed in order to comply with the FDA’s request..."
https://techcrunch.com/2020/03/23/updated-fda-covid-19-testing-guidelines-specifically-disallows-at-home-sample-colllection/
https://marginalrevolution.com/marginalrevolution/2020/03/fda-stops-at-home-tests.html